Emerging evidence show WNT3A [37, 38], WNT16B [39] and WNT5A [34] are essential in PCA for its initial, development, progression and therapy resistance, which may be autocrine or paracrine from stroma. This evidence concerns the gene WNT3A and posterior cortical atrophy.